Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brain Power Spectral Density Under Propofol and Its Association With Cerebral Fragility, an Objective Means to Estimate the Probability of Presenting Burst Suppression

NCT03876379 is registered in ClinicalTrials.gov with Joaquim MATEO as lead sponsor.

NCT NCT03876379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03876379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brain Power Spectral Density Under Propofol and Its Association With Cerebral Fragility, an Objective Means to Estimate the Probability of Presenting Burst Suppression
Lead sponsor
Joaquim MATEO
Phase
Observational
Overall status
Completed
Start date
January 24, 2015
Completion date
January 5, 2016
Enrollment
60 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

interventional, orthopedic surgery, radiography